India's Pharmaceutical Exports

Country Profile

Tunisia

Tunisia is an emerging destination for Indian pharmaceutical exports — $24.1M in FY 2025–26, with 3.8× growth over the past decade. Medicines accounts for 32% of shipments, with vaccines contributing $7.04M. The compound annual growth rate since FY2015 stands at 12.9%.

🇹🇳 $24.1M · 3.8× growth since FY2015 · 12.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$24.1M
Exports FY2025–26 DGCIS
3.8×
Growth FY2015→2026
12.9%
CAGR FY2015→2026
32%
Medicines Share
5
Product Categories Supplied
Tunisia is an emerging destination for Indian pharmaceutical exports — $24.1M in FY 2025–26, with 3.8× growth over the past decade. Medicines accounts for 32% of shipments, with vaccines contributing $7.04M. The compound annual growth rate since FY2015 stands at 12.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $7.81M (32.4%) Medicine Ingredients $7.64M (31.7%) Vaccines $7.04M (29.2%) Surgical & Hospital Supplies $1.46M (6.1%) Traditional & Herbal $146K (0.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Tunisia in the RBI overseas direct investment dataset (2011–2026).